Annovis Bio, Inc. (ANVS)

Annovis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.29	10.55	5.75	28.38	45.69	8.07
Cash & Short-Term Investments	15.29	10.55	5.75	28.38	45.69	8.07
Cash Growth	20.97%	83.36%	-79.72%	-37.89%	465.79%	434488.70%
Prepaid Expenses	1.9	0.37	0.04	0.1	0.07	0.04
Other Current Assets	0.01	3.01	4.41	7.54	0.24	0.01
Total Current Assets	17.19	13.93	10.21	36.02	46	8.12
Total Assets	17.19	13.93	10.21	36.02	46	8.12
Accounts Payable	2.11	2.31	1.29	3.96	0.69	0.34
Accrued Expenses	1.62	1.58	2.99	3.74	0.82	0.24
Total Current Liabilities	3.73	3.88	4.28	7.7	1.51	0.58
Other Long-Term Liabilities	0.3	0.74	13.68	-	-	-
Total Liabilities	4.03	4.62	17.96	7.7	1.51	0.58
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	167.02	144.16	102.51	82.38	73.22	21.78
Retained Earnings	-153.87	-134.85	-110.26	-54.05	-28.73	-14.24
Total Common Equity	13.16	9.31	-7.75	28.32	44.49	7.54
Shareholders' Equity	13.16	9.31	-7.75	28.32	44.49	7.54
Total Liabilities & Equity	17.19	13.93	10.21	36.02	46	8.12
Net Cash (Debt)	15.29	10.55	5.75	28.38	45.69	8.07
Net Cash Growth	20.97%	83.36%	-79.72%	-37.89%	465.79%	-
Net Cash Per Share	0.86	0.86	0.64	3.48	5.99	1.28
Filing Date Shares Outstanding	26.5	19.49	11.01	8.22	8.16	6.95
Total Common Shares Outstanding	20.19	14.14	10.52	8.16	8.1	6.89
Working Capital	13.46	10.04	5.93	28.32	44.49	7.54
Book Value Per Share	0.65	0.66	-0.74	3.47	5.49	1.09
Tangible Book Value	13.16	9.31	-7.75	28.32	44.49	7.54
Tangible Book Value Per Share	0.65	0.66	-0.74	3.47	5.49	1.09

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q